Prostate Cancer

Trial Add-Aspirin Trial
Cancer Type Bowel Cancer, Gastrointestinal, Genitourinary, Miscellaneous, Oesophageal Cancer, Prostate Cancer, Stomach Cancer, and Non-specific
Hospital(s) Belfast City Hospital
Information

A Phase III, Double-Blind, Placebo-Controlled Randomised Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival after Primary Therapy in Common Non-Metastatic Solid Tumours

Click Here to view CancerHelpUK trial summary
Trial AMPLITUDE
Cancer Type Prostate Cancer
Hospital(s) Belfast City Hospital
Information

A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants with Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

Trial Immune gene expression and tumour microenvironment in prostate cancer
Cancer Type Genitourinary and Prostate Cancer
Hospital(s) Belfast City Hospital
Information

How does radiotherapy affect immune gene expression and the tumour microenvironment in men with localised prostate cancer?

Trial INTERVAL (GAP 4)
Cancer Type Genitourinary and Prostate Cancer
Hospital(s) Belfast City Hospital
Information

Intense Exercise for Survival Among Men With Metastatic Castrate-Resistant Prostate Cancer (INTERVAL – MCRPC): A Multicenter, Randomised, Controlled, Phase III Study

Trial Lantern Pharma
Cancer Type Prostate Cancer
Hospital(s) Altnagelvin Hospital
Information

Biomarker analysis using fresh biopsy tissue

Trial Pivotal Boost
Cancer Type Genitourinary and Prostate Cancer
Hospital(s) Belfast City Hospital
Information

A Phase III Randomised Controlled Trial of Prostate and Pelvis Versus Prostate Alone Radiotherapy With Or Without Prostate Boost

Trial PROCADE
Cancer Type Genitourinary and Prostate Cancer
Hospital(s) Belfast City Hospital
Information

A Multinational, Phase 3, Randomized, Double-Blind, Non-Inferiority, Efficacy and Safety Study of Oral HC-1119 versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Trial SPORT High-Risk Trial
Cancer Type Genitourinary and Prostate Cancer
Hospital(s) Belfast City Hospital
Information

A Randomised Feasibility Study Evaluating Stereotactic Prostate Radio Therapy In High-Risk Localised Prostate Cancer With Or Without Elective Nodal Irradiation

Click Here to view CancerHelpUK trial summary
Trial Stampede
Cancer Type Genitourinary and Prostate Cancer
Hospital(s) Belfast City Hospital
Information

Systemic Therapy in Advancing or Metastatic Prostate cancer – Evaluation of Drug Efficacy

Click Here to view CancerHelpUK trial summary
Trial UKGPC
Cancer Type Genitourinary and Prostate Cancer
Hospital(s) Altnagelvin Hospital, Antrim Hospital, and Ulster Hospital
Information

UK Genetics Prostate Cancer Study

Click Here to view CancerHelpUK trial summary